Health & Nutrition

FNArena Windows (Sectors)

Introduction to FNArena Windows

FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.

Latest Stories

The New Criterion’s Tim Boreham highlights some interesting health and wellness stocks to monitor

Apr 29 2021

Having completed its efficiency drive, Sigma Healthcare is looking to M&A to enable future growth

Mar 24 2021


ASX CODE COMPANY NAME LAST PRICE 52WK HIGH 52WK LOW P/E CONSENSUS TARGET
API AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED $1.74 $1.77 $0.00 18.8

$1.493

BKL BLACKMORES LIMITED $89.34 $103.97 $63.17 40.5

$89.40

CLV CLOVER CORPORATION LIMITED $1.63 $1.98 $0.00 31.0

$1.875

EBO EBOS GROUP LIMITED $34.00 $37.00 $23.53 27.1

$34.25

MCP MCPHERSON'S LIMITED $0.88 $1.55 $0.00 11.3

$1.20

SIG SIGMA HEALTHCARE LIMITED $0.53 $xx.xx $xx.xx xx.x xx.xx
Previous Stories
McPherson’s Expands Into Herbal Health

Nov 04 2020

McPherson’s has expanded into the herbal product segment by acquiring Global Therapeutics and can now build out that business across its pharmacy distribution channel.


Nine Ignored Companies Now Worth A Look

Sep 23 2020

Peter Switzer of the Switzer Report highlights nine stocks that aren’t his top picks, but that analysts believe offer solid upside ahead.


Next Week At A Glance – 14-18 Sep 2020

Sep 11 2020

A brief look at important company events and economic data releases next week


Sigma Farewells API, Heralds New Contract

Dec 17 2019

Sigma Healthcare has adjusted guidance to account for the renewed Chemist Warehouse contract, while Australian Pharmaceutical Industries finally takes its hat out of the merger ring.


Blackmores: Hopes Pinned On Restructuring

Nov 01 2019

Blackmores’ first half profit warning has sent analysts into a scramble to downgrade forecasts, but turnaround potential has been boosted by a shift in strategy.


Blackmores Peps Up Its Strategy For China

Apr 17 2019

Elevated inventory persisted over the March quarter amid falling sales for Blackmores, which has recognised the need to reposition its business to better cater for the Chinese market.


API/Sigma Merger Plan Rears, Again

Dec 17 2018

A merger of Australian Pharmaceutical Industries and Sigma Healthcare is logical but ACCC issues are uppermost in broker views.


Uncertainty Hinders Sigma Pharmaceuticals

Sep 11 2018

Uncertainty is likely to hinder Sigma Pharmaceuticals until a firm earnings base is established after the exit of its major customer.


Goodbye Chemist Warehouse, Hello Capital Return?

Jul 03 2018

Stockbrokers are still not keen on buying Sigma Healthcare shares, though a capital return might change their view.


Healthier Growth Required From Blackmores

Apr 27 2018

Several issues, mostly one-off, plagued Blackmores in the March quarter and some brokers query whether the growth profile justifies the elevated valuation.